As of April 30, 2026, Alzai Health Corp. maintains a current ratio of 0.33, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -63.14, indicating conservative leverage, while an interest coverage ratio of -105.93 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.33 |
| Quick Ratio | 0.30 |
| Debt / Equity | -63.14 |
| Debt / EBITDA | -0.23 |
| Interest Coverage | -105.93 |
These figures cover the twelve months ended April 30, 2026. EBITDA reached -2.26M, while operating income came in at -2.27M.
| Revenue | 16,958.97 |
| Operating Income | -2.27M |
| Pretax Income | -2.31M |
| Net Income | -2.31M |
| EBITDA | -2.26M |
| EBIT | -2.27M |
As of April 30, 2026, Alzai Health Corp. holds 168,137.05 in cash and equivalents against 523,018.40 in total debt, resulting in a net debt position of 354,881.35. Total book value stands at -828,356.30, with working capital of -546,049.96 providing operational flexibility.
| Cash & Cash Equivalents | 168,137.05 |
| Total Debt | 523,018.40 |
| Net Debt | 354,881.35 |
| Equity (Book Value) | -828,356.30 |
| Working Capital | -546,049.96 |
Alzai Health Corp. produced -1.63M in operating cash flow over the twelve months ended April 30, 2026.
| Operating Cash Flow | -1.63M |
| Capital Expenditures | -12,170.89 |
| Free Cash Flow | -1.64M |
These figures cover the twelve months ended April 30, 2026. The operating margin of -13,405.82 and net profit margin of -13,593.12 provide insight into operational efficiency.
| Operating Margin | -13,405.82 |
| Pretax Margin | -13,593.12 |
| Profit Margin | -13,593.12 |
| EBITDA Margin | -13,345.08 |
Already premium?